So on the horizontal axis we have
the dose shown in nanograms.
On the vertical axis we have
the immune response generated,
and that dashed line indicates
the protection threshold.
If we're above that line it's considered protective;
if we're below that line it's not.
So the red line is mostly below that curve
and indeed there's only one point that
is achieved with the needle that's protective,
and that's with a high dose of 6,000 nanograms.
But notice immediately the distinctly different curve
that we achieve with the blue line.
That's what's achieved with the Nanopatch;
the delivered dose of the Nanopatch is
a completely different immunogenicity curve.
That's a real fresh opportunity.
Suddenly we have a brand new lever
in the world of vaccines.
We can push it one way,
where we can take a vaccine
that works but is too expensive
and can get protection
with a hundredth of the dose
compared to the needle.
That can take a vaccine that's suddenly
10 dollars down to 10 cents,